For the Inventor, By the Inventor

Enter assignee name

Barcelona, Spain

Universität De Barcelona

Calculating rank

USPTO Granted Patents = 56

% Expired Patents = 14.3

CIPO Patents = 2

EPO Patents = 45

Forward Citations = 43

Loading Chart...

Loading Chart...

248 inventors (with patents filed for the assignee):

Joseph M Connors (7 out of 10 patents)

Erlend B Smeland (6 out of 7 patents)

Elaine S Jaffe (6 out of 7 patents)

4. Louis M Staudt (6 out of 9 patents)

5. German Ott (6 out of 6 patents)

6. Lisa M Rimsza (5 out of 6 patents)

7. Wing C Chan (5 out of 6 patents)

8. Jan Delabie (5 out of 6 patents)

9. Randy D Gascoyne (5 out of 8 patents)

10. Dennis Weisenburger (5 out of 6 patents)

11. Kai Fu (5 out of 6 patents)

12. Harald Holte (4 out of 4 patents)

13. Rita M Braziel (4 out of 5 patents)

14. Richard I Fisher (4 out of 4 patents)

15. Armando Lopez-Guillermo (4 out of 4 patents)

Core Competencies:

Colorectal Cancer

B-Cell Acute Lymphoblastic Leukemia

CAR T-Cells

Neurodegenerative Diseases

Mitochondrial Markers

Lymphoma Diagnosis

Bioreactor

Organometallic Compounds

Functionalized Liposomes

Signal Processing

Microscopic Imaging

Barocaloric Devices

56 patents: Sort by Forward Citations

1. 12766171 - Long-term stable live fecal microbiota composition (2026-10-20),

2. 12668846 - Non-invasive method for the diagnosis or screening of colorectal cancer and/or pre-cancerous stage thereof (2026-06-30),

3. 12648932 - ERGOTHIONEINE, S-METHYL-ERGOTHIONEINE, AND USES THEREOF (2026-06-09),

4. 12625356 - Programmable multiple-point illuminator, confocal filter, confocal microscope and method to operate said confocal microscope (2026-05-12),

5. 12557544 - Organometallic compound, composition including same, organic light-emitting device, and electronic apparatus (2026-02-17),

6. 12522666 - CD22 TARGETING-MOIETY FOR THE TREATMENT OF B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA (B-ALL) (2026-01-13),

7. 12521422 - Long-term stable live fecal microbiota composition (2026-01-13),

8. 12509525 - CAR T-CELLS AGAINST BCMA FOR THE TREATMENT OF MULTIPLE MYELOMA (2025-12-30),

9. 12486222 - COMPOUNDS AS SOLUBLE EPOXIDE HYDROLASE INHIBITORS (2025-12-02),

10. 12459973 - Peptide compounds for reducing side effects of CB1 receptor agonists (2025-11-04),

11. 12393012 - Methods and device for obtaining microscopic digital images (2025-08-19),

12. 12286439 - Inhibitors of ERK nuclear translocation (2025-04-29),

13. 12236804 - Methods and systems for gradual exposure to a fear (2025-02-25),

14. 12181410 - Sensing arrangement and corresponding detector device (2024-12-31),

15. 12120947 - Organometallic compound, composition including same, organic light-emitting device, and electronic apparatus (2024-10-15),

Company Overview

Universität De Barcelona is a prominent academic institution located in Barcelona, Spain, specializing in advanced research and education in the field of cancer treatment. The university focuses on innovative therapies for various cancers, including colorectal cancer and B-Cell Acute Lymphoblastic Leukemia, utilizing cutting-edge technologies such as CAR T-Cells. Additionally, it explores neurodegenerative diseases and employs bioreactor systems for research, contributing to advancements in lymphoma diagnosis and the study of organometallic compounds.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

56 Patents

#8 in Barcelona

#20 in Spain

#12,772 in the World

Barcelona, Spain

Universität De Barcelona

Forward Citations = 43

248 inventors:

Joseph M Connors (7 out of 10 patents)

Erlend B Smeland (6 out of 7 patents)

Elaine S Jaffe (6 out of 7 patents)

4. Louis M Staudt (6 out of 9 patents)

5. German Ott (6 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Universität De Barcelona. Retrieved from https://idiyas.com/company/universitat-de-barcelona

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…